Applied Human Genetics
SCI 115
1. A biotechnology company offers a direct-to-consumer test called the Carrier Status report
that generates various calculations about an individual's genetic risk for certain diseases.
A direct-to-customer test would be valuable on the grounds that autosomal latent examples
of a legacy show up just in homozygous people. At the point when people need to begin a
family, it would be valuable to comprehend what acquired alleles are impacting everything.
Knowledge of your alleles are identical(homozygous) or different(heterozygous) could
lessen the danger of passing an illness. "Any offspring of two transporters have a have
percent possibility of acquiring the allele from the two guardians and fostering the attribute."
While picking an accomplice, you would need to utilize this transporter status report to assist
you with picking an accomplice that is not conveying a similar duplicate of the infection
allele to decrease the general danger. Utilizing this data would assist a couple with staying
away from autosomal latent legacy sicknesses like Cystic fibrosis, Friedreich's ataxia, or
sickle cell iron deficiency.
2. The Carrier Status report mentioned above is packaged along with a Genetic Health
Risk report. Neither has been approved by the FDA for diagnosing illness. They have
only been approved for general informational purposes about an individual's health
risks.